LMAT - Company ID 0001158895
The table below shows LEMAITRE VASCULAR INC's income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Revenue | $249.60M | $219.86M | $193.48M | $161.65M | $154.42M | $129.37M |
| Cost of revenue | $71.06M | $68.96M | $66.44M | $56.76M | $53.04M | $44.75M |
| Gross profit | $178.54M | $150.90M | $127.05M | $104.90M | $101.38M | $84.62M |
| R&D | $14.14M | $15.65M | $16.97M | $13.29M | $11.80M | $10.10M |
LEMAITRE VASCULAR INC reported annual revenue of $249.60M for fiscal year 2025. That is up 13.5% from $219.86M in fiscal 2024. Over the 10 fiscal years shown, annual revenue grew from $89.15M (FY 2016) to $249.60M. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| SG&A |
| $42.02M |
| $36.26M |
| $31.83M |
| $28.75M |
| $25.50M |
| $22.50M |
| Operating income | $67.91M | $52.26M | $36.71M | $26.83M | $36.42M | $28.79M |
| Income tax | $17.45M | $12.84M | $9.37M | $6.85M | $7.38M | $6.14M |
| Net income | $57.70M | $44.00M | $30.10M | $20.60M | $26.90M | $21.22M |
| EPS (diluted) | $2.52 | $1.93 | $1.34 | $0.93 | $1.25 | $1.04 |